Back to News
Market Impact: 0.3

Truist reiterates Hold on Hims and Hers stock, $32 target

Source: Investing.com

Healthcare & BiotechCompany FundamentalsAnalyst InsightsConsumer Demand & RetailLegal & Litigation
Truist reiterates Hold on Hims and Hers stock, $32 target

Truist reiterated a Hold rating on Hims & Hers with a $32 price target as its card data showed September GLP-1 billings down 16% month over month per day and transactions down 11%; Q3 billings and transactions were up 22% and 21% quarter over quarter, respectively. September figures are provisional and may be revised when October data arrive; average transaction duration also declined. Separately, the company was enrolled in Visa’s Acquirer Monitoring Program after increased disputes tied to its weight-loss subscriptions, with an $8 surcharge per dispute and nearly $75,000 in anticipated fees.

Analysis

The actionable signal is not the provisional September card-data decline alone: Truist’s history shows the latest month can be revised as later transactions are classified. But the deterioration in transaction-weighted duration alongside weaker monthly activity is a more important watch item than billings by themselves. If it persists, shorter customer tenure could make reported acquisition growth less valuable by increasing replacement marketing and onboarding needs. Q3 sequential growth argues against treating one provisional month as a confirmed break in demand.

The Visa monitoring issue is small in stated direct dollars, but could matter more through payment acceptance, dispute controls, or customer friction if the program escalates. That creates a potential feedback loop: more disputes raise payment costs and friction, which can worsen retention and further pressure subscription economics. Verify dispute rates and Visa program status before assigning material earnings impact. Australia broadens the opportunity set, but is not yet evidence that international growth offsets any U.S. GLP-1 slowdown.

Near term, expect HIMS shares to trade on revisions to card data and updates on payment disputes; the article’s oil-shipping headline is unrelated to the company-specific evidence and should not drive positioning. Over 1–3 months, October card data should help validate September activity. Over 6–18 months, the key question is whether branded offerings and geographic expansion support durable retention and attractive unit economics, not just top-line growth. The supplied valuation claim is not independently substantiated here, so it is not a standalone short thesis.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.15

Ticker Sentiment

HIMS-0.40

Key Decisions for Investors

  • No immediate directional position on HIMS from this report alone. Treat September card data as provisional; revisit after October data and company disclosures clarify GLP-1 transactions, duration, and branded membership.
  • Set an alert for evidence that transaction-weighted duration continues to fall or that management revises growth or margin expectations downward. Persistent deterioration would strengthen a cautious or short thesis; stabilization alongside Q3 growth would weaken it.
  • Track Visa monitoring status, dispute rates, and any change in payment acceptance or dispute costs. Escalation or measurable customer friction—not the stated surcharge total by itself—would be the relevant downside catalyst.
  • For a 6–18 month thesis, require evidence that branded GLP-1 and Australia expansion contribute durable customers and acceptable economics. Until then, treat expansion as optionality rather than an offset to U.S. demand risk.

More News

From AllMind Research

Browse all research